Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
A federal judge ordered Johnson & Johnson's unit to pay $1.64 billion to the U.S. government for illegally promoting HIV drugs. The jury found violations of the False Claims Act, leading to civil fines imposed. Johnson & Johnson plans to appeal the verdict.